Jardiance and Azopt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Jardiance (empagliflozin) and Azopt (brinzolamide). Common drug interactions include alopecia among females and septic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Jardiance and Azopt. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Jardiance?

Jardiance has active ingredients of empagliflozin. It is often used in hyperglycemia. eHealthMe is studying from 44,459 Jardiance users. Check the latest studies of Jardiance.

What is Azopt?

Azopt has active ingredients of brinzolamide. It is often used in glaucoma. eHealthMe is studying from 8,058 Azopt users. Check the latest studies of Azopt.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

11 people who take Jardiance and Azopt together, and have interactions are studied.

What are the common drug interactions of Jardiance and Azopt, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Hair colour changes
Hair disorder
Plasma cell myeloma (cancer that begins in plasma cells)

male:

Septic shock (shock due to blood infection)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Renal failure (kidney dysfunction)
Skin mass
Urine ketone body present
Urine output increased
Weight decreased
Arrhythmia (irregular heartbeat)
Blood glucose increased
Cardiac arrest

What are the common drug interactions of Jardiance and Azopt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Alopecia (absence of hair from areas of the body)
Hair colour changes
Hair disorder

50-59:

Plasma cell myeloma (cancer that begins in plasma cells)

60+:

Septic shock (shock due to blood infection)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Renal failure (kidney dysfunction)
Skin mass
Urine ketone body present
Urine output increased
Weight decreased
Arrhythmia (irregular heartbeat)
Blood glucose increased
Cardiac arrest

What are the existing conditions these people have? *

Type 2 Diabetes: 4 people, 36.36%
Breast Cancer Female: 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
Erection Problems: 2 people, 18.18%
Urinary Tract Infection: 1 person, 9.09%
Dyspnea (difficult or laboured breathing): 1 person, 9.09%
Cardiac Disorder: 1 person, 9.09%
Chest Pain: 1 person, 9.09%
Constipation: 1 person, 9.09%
Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Jardiance and Azopt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously